Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MR-proADM as prognostic factor of outcome in COVID-19 patients.
Sozio E, Tascini C, Fabris M, D'Aurizio F, De Carlo C, Graziano E, Bassi F, Sbrana F, Ripoli A, Pagotto A, Giacinta A, Gerussi V, Visentini D, De Stefanis P, Merelli M, Saeed K, Curcio F. Sozio E, et al. Among authors: graziano e. Sci Rep. 2021 Mar 4;11(1):5121. doi: 10.1038/s41598-021-84478-1. Sci Rep. 2021. PMID: 33664308 Free PMC article.
Prevention and treatment of recurrent cellulitis.
Peghin M, Graziano E, Rovelli C, Grossi PA. Peghin M, et al. Among authors: graziano e. Curr Opin Infect Dis. 2023 Apr 1;36(2):95-101. doi: 10.1097/QCO.0000000000000903. Epub 2023 Feb 9. Curr Opin Infect Dis. 2023. PMID: 36853755 Review.
Skin and soft tissue infections in solid organ transplants.
Peghin M, Graziano E, Grossi PA. Peghin M, et al. Among authors: graziano e. Curr Opin Infect Dis. 2024 Apr 1;37(2):112-120. doi: 10.1097/QCO.0000000000000998. Epub 2023 Dec 4. Curr Opin Infect Dis. 2024. PMID: 38050739 Review.
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito AR, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE Study Group. Bassetti M, et al. Int J Antimicrob Agents. 2019 Apr;53(4):408-415. doi: 10.1016/j.ijantimicag.2018.11.001. Epub 2018 Nov 8. Int J Antimicrob Agents. 2019. PMID: 30415002 Free article.
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study).
Bassetti M, Vena A, Giacobbe DR, Falcone M, Tiseo G, Giannella M, Pascale R, Meschiari M, Digaetano M, Oliva A, Rovelli C, Carannante N, Losito AR, Carbonara S, Mariani MF, Mastroianni A, Angarano G, Tumbarello M, Tascini C, Grossi P, Mastroianni CM, Mussini C, Viale P, Menichetti F, Viscoli C, Russo A; CEFTABUSE Study Group. Bassetti M, et al. Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa139. doi: 10.1093/ofid/ofaa139. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32462046 Free PMC article.
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
Peghin M, Bouza E, Fabris M, De Martino M, Palese A, Bontempo G, Graziano E, Gerussi V, Bressan V, Sartor A, Isola M, Tascini C, Curcio F. Peghin M, et al. Among authors: graziano e. Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2597-2604. doi: 10.1007/s10096-021-04335-x. Epub 2021 Aug 11. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34378086 Free PMC article.
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
Peghin M, De Martino M, Fabris M, Palese A, Visintini E, Graziano E, Gerussi V, Bontempo G, D'Aurizio F, Biasotto A, Sartor A, Pipan C, Marzinotto S, Curcio F, Bouza E, Isola M, Tascini C. Peghin M, et al. Among authors: graziano e. J Clin Microbiol. 2021 Oct 19;59(11):e0113821. doi: 10.1128/JCM.01138-21. Epub 2021 Aug 11. J Clin Microbiol. 2021. PMID: 34379530 Free PMC article.
90 results